Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT06353724 |
Other study ID # |
RP2218 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
October 14, 2019 |
Est. completion date |
January 1, 2021 |
Study information
Verified date |
April 2024 |
Source |
Tanta University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The goal of this clinical trial is to compare between the Effect of Using Conventional and
Digital Oral Positional Radiation Stent on Healthy tissues, salivary PH. The main question it
aims to answer are: Does the difference in manufacturing method affect on Healthy tissues,
salivary PH.
Participants will use radiation positioning stent during radiotherapy sessions Two groups
will be compared
- Group A: OPRS was constructed according to the conventional technique.
- Group B: OPRS was constructed digitally using CAD /CAM technology. to evaluate
Dosimetric analysis to quantify the radiation dose in OARs, PH of saliva measurement and
Mucositis assessment.
Description:
This study will be a clinically prospective study that will include 16 patients with head and
neck cancer. This study will be carried out at the Clinical Prosthodontics Department &
Clinical Oncology Department of Tanta University.
Informed consent will be obtained from all patients with maintenance of their privacy prior
to inclusion in the study according to the guidelines on human research adopted by the
Research Ethics Committee, Faculty of Dentistry, Tanta University.
Patient's evaluation:
All patients will be subjected to the following protocol:
Oral examination: Clinical dental evaluation, intraoral photography and mouth opening
measurements
Grouping: The patients will be divided randomly into 2 groups (each group consists of 8
patients) according to the technique that will be used for construction:
First group: The OPRS will be constructed according to the conventional technique.27
Second group: The OPRS will be constructed digitally according to the following steps:
Intraoral scanning: It will be done using an intraoral scanner to generate three 3D images:
the first of the superior arch, the second of the inferior arch, and the third of the maximum
habitual intercuspation. Images will be compiled into a 3D file system.
Oral positioning radiation stent design: The compiled file will be exported into Exocad
software, which is smart software for dental design on digital models, for stent design, and
by using a virtual articulator.
3D printing: After optimizing the digital file, 3D printing will be performed. The oral
positioning radiation stent will be printed using the 3D printer Resin Printing Material.
For both groups:
Insertion: making the necessary adjustment will be done.
RT techniques and dose distributions:
All patients will be referred to the RT department for IMRT planning. During the
pre-irradiation simulation, the intraoral stents will be placed, and the patients will be
immobilized by individual thermoplastic masks. A computed tomography scan will be conducted
to determine the precise planning target volume (PTV); all patients will be scanned using the
positional prosthesis once and without it.
Dosimetric analysis:
To quantify the radiation dose in the structures, the maxilla (area of the teeth), both
parotid glands (ipsilateral and contralateral), the mandible, and the PTV will be defined and
contoured in computed tomography pre-irradiation planning. The mean corresponding dose of
each structure will be acquired using a dose-volume histogram.
All patients will complete the radiotherapy sessions using the positional radiation
prosthesis together with the extra oral immobilization masks.
Mucositis assessment:
The severity of mucositis will be assessed weekly from the beginning of RT to the end of the
treatment (mean time, 7 weeks). It will be scored in accordance with the classification
criteria of the National Cancer Institute.
PH of saliva measurement:
A saliva sample will be collected from each patient to measure salivary PH by digital PH
meter 19 before the beginning of radiotherapy, and the measurement will be continued weekly
until the end of the treatment.